- Conditions
- Peripheral Artery Disease
- Interventions
- Human Acellular Vessel (HAV)
- Biological
- Lead sponsor
- Humacyte, Inc.
- Industry
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2023
- U.S. locations
- 5
- States / cities
- San Francisco, California • Boston, Massachusetts • Flint, Michigan + 2 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–5
of 5
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Renal Failure, End Stage Renal Disease, Hemodialysis, Vascular Access
- Interventions
- Human Acellular Vessel (HAV), ePTFE graft
- Biological · Device
- Lead sponsor
- Humacyte, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 355 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2023
- U.S. locations
- 22
- States / cities
- Phoenix, Arizona • Tucson, Arizona • Fresno, California + 18 more
- Conditions
- Trauma, Vascular System Injury
- Interventions
- Acellular Tissue Engineered Vessel (ATEV)
- Biological
- Lead sponsor
- Humacyte, Inc.
- Industry
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 72 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2026
- U.S. locations
- 27
- States / cities
- La Jolla, California • Los Angeles, California • Orange, California + 18 more
- Conditions
- End Stage Renal Disease (ESRD)
- Interventions
- Acellular Tissue Engineered Vessel (ATEV), AVF
- Biological · Other
- Lead sponsor
- Humacyte, Inc.
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 121 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2028
- U.S. locations
- 32
- States / cities
- Scottsdale, Arizona • El Centro, California • La Jolla, California + 25 more
- Conditions
- Renal Failure, End Stage Renal Disease, Hemodialysis, Vascular Access
- Interventions
- Human Acellular Vessel (HAV), Arteriovenous fistula (AVF), Hemodialysis
- Biological · Procedure · Other
- Lead sponsor
- Humacyte, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 242 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2025
- U.S. locations
- 31
- States / cities
- Phoenix, Arizona • Tucson, Arizona • Irvine, California + 27 more